CTA
CNMD icon

Carillon Tower Advisers’s CONMED CNMD Stock Holding History

Carillon Tower Advisers’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$37.5M Buy
334,488
+166,671
+99% +$15.8M 0.23% 134
2020
Q3 		$13.2M Buy
167,817
+11,285
+7% +$920K 0.18% 214
2020
Q2 		$11.3M Hold
156,532
– – 0.09% 283
2020
Q1 		$7.88M Hold
156,532
– – 0.08% 300
2019
Q4 		$17.5M Buy
156,532
+50,000
+47% +$5.33M 0.12% 277
2019
Q3 		$10.2M Buy
+106,532
New +$10M 0.07% 329

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Carillon Tower Advisers's CNMD Position: Q4 2020 in Review

Carillon Tower Advisers increased its CONMED (CNMD) stake by 99% in Q4 2020, buying an estimated $15.8M and bringing the position to 334,488 shares worth $37.5M. The position accounts for 0.23% of the portfolio, ranked #134.

Carillon Tower Advisers first reported a position in CNMD in Q3 2019 and has held it in 6 quarters since. 249 funds tracked by Wall St. Rank hold CNMD as of Q4 2020.

  • Carillon Tower Advisers held 334,488 shares of CONMED worth $37.5M as of Q4 2020.
  • Carillon Tower Advisers bought 166,671 CONMED shares in Q4 2020, an estimated $15.8M.
  • CONMED made up 0.23% of Carillon Tower Advisers's portfolio in Q4 2020, its #134 holding.
  • Carillon Tower Advisers first reported a position in CONMED in Q3 2019 and has held it in 6 quarters since.
  • 249 funds tracked by Wall St. Rank held CONMED as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.